Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

[Reflective experience--or: what is it a medical practitioner expects from a medical historian].

Hadding U.

Sudhoffs Arch Z Wissenschaftsgesch Beih. 2004;(54):57-64. German. No abstract available.

PMID:
15376443
2.

Staphylococcus aureus small colony variants: rate of selection and MIC values compared to wild-type strains, using ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacin.

Schmitz FJ, von Eiff C, Gondolf M, Fluit AC, Verhoef J, Peters G, Hadding U, Heinz HP, Jones ME.

Clin Microbiol Infect. 1999 Jun;5(6):376-378. No abstract available.

3.
4.
5.

Interleukin-1 inhibits gamma interferon-induced bacteriostasis in human uroepithelial cells.

Däubener W, Hucke C, Seidel K, Hadding U, MacKenzie CR.

Infect Immun. 1999 Nov;67(11):5615-20.

7.

Cyto-adherence studies of the adhesin P50 of Mycoplasma hominis.

Kitzerow A, Hadding U, Henrich B.

J Med Microbiol. 1999 May;48(5):485-93.

PMID:
10229546
8.
9.

Inducible anti-parasitic effector mechanisms in human uroepithelial cells: tryptophan degradation vs. NO production.

Däubener W, Posdziech V, Hadding U, MacKenzie CR.

Med Microbiol Immunol. 1999 Mar;187(3):143-7.

PMID:
10206145
10.

The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus.

Schmitz FJ, Fluit AC, Lückefahr M, Engler B, Hofmann B, Verhoef J, Heinz HP, Hadding U, Jones ME.

J Antimicrob Chemother. 1998 Dec;42(6):807-10.

PMID:
10052906
11.
12.

Truncation as a novel form of variation of the p50 gene in Mycoplasma hominis.

Henrich B, Lang K, Kitzerow A, MacKenzie C, Hadding U.

Microbiology. 1998 Nov;144 ( Pt 11):2979-85.

PMID:
9846733
13.

Cloning and expression of P60, a conserved surface-localized protein of Mycoplasma hominis, in Escherichia coli.

Henrich B, Berns G, Weinhold M, Kitzerow A, Schaal H, Hadding U.

Biol Chem. 1998 Aug-Sep;379(8-9):1143-50.

PMID:
9792448
15.

Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC.

Schmitz FJ, Jones ME, Hofmann B, Hansen B, Scheuring S, Lückefahr M, Fluit A, Verhoef J, Hadding U, Heinz HP, Köhrer K.

Antimicrob Agents Chemother. 1998 May;42(5):1249-52.

16.

Development of a multiplex-PCR for direct detection of the genes for enterotoxin B and C, and toxic shock syndrome toxin-1 in Staphylococcus aureus isolates.

Schmitz FJ, Steiert M, Hofmann B, Verhoef J, Hadding U, Heinz HP, Köhrer K.

J Med Microbiol. 1998 Apr;47(4):335-40.

PMID:
9569000
17.

Impact of hygienic measures on the development of methicillin resistance among staphylococci between 1991 and 1996 in a university hospital.

Schmitz FJ, Verhoef J, Idel H, Hadding U, Heinz HP, Jones ME.

J Hosp Infect. 1998 Mar;38(3):237-40. No abstract available.

PMID:
9561477
18.

Methicillin resistant Staphylococcus aureus strains in the greater Düsseldorf area.

Schmitz FJ, MacKenzie CR, Geisel R, Wagner S, Idel H, Verhoef J, Hadding U, Heinz HP.

Eur J Epidemiol. 1997 Sep;13(6):709-17.

PMID:
9324219
19.

Enterotoxin and toxic shock syndrome toxin-1 production of methicillin resistant and methicillin sensitive Staphylococcus aureus strains.

Schmitz FJ, MacKenzie CR, Geisel R, Wagner S, Idel H, Verhoef J, Hadding U, Heinz HP.

Eur J Epidemiol. 1997 Sep;13(6):699-708.

PMID:
9324218
20.
21.

Cytokine responses induced by Toxoplasma gondii in astrocytes and microglial cells.

Fischer HG, Nitzgen B, Reichmann G, Hadding U.

Eur J Immunol. 1997 Jun;27(6):1539-48.

PMID:
9209508
22.

Cellular immune reactions directed against Toxoplasma gondii with special emphasis on the central nervous system.

Däubener W, Hadding U.

Med Microbiol Immunol. 1997 Mar;185(4):195-206. Review.

PMID:
9138291
23.

Host cells of Toxoplasma gondii encystation in infected primary culture from mouse brain.

Fischer HG, Nitzgen B, Reichmann G, Gross U, Hadding U.

Parasitol Res. 1997;83(7):637-41.

PMID:
9272550
24.

Biovar-specific epitopes of the urease enzyme of Ureaplasma urealyticum.

MacKenzie CR, Henrich B, Hadding U.

J Med Microbiol. 1996 Nov;45(5):366-71.

PMID:
8918953
25.

Repetitive elements of the Mycoplasma hominis adhesin p50 can be differentiated by monoclonal antibodies.

Henrich B, Kitzerow A, Feldmann RC, Schaal H, Hadding U.

Infect Immun. 1996 Oct;64(10):4027-34.

26.

Protamine enhances the activity of human recombinant interferon-gamma.

Däubener W, Gutsche M, Nockemann S, MacKenzie C, Seghrouchni S, Hadding U.

J Interferon Cytokine Res. 1996 Jul;16(7):531-6.

PMID:
8836919
27.
28.

[Typing, resistance behavior and occurrence of methicillin-resistant Staphylococcus aureus strains in a surgical intensive care unit].

Schmitz FJ, Geisel R, Wagner S, Lenz W, Kamla V, Heinz HP, Idel H, Hadding U.

Zentralbl Hyg Umweltmed. 1996 Mar;198(4):355-80. German.

PMID:
9376060
29.

Anti-parasitic effector mechanisms in human brain tumor cells: role of interferon-gamma and tumor necrosis factor-alpha.

Däubener W, Remscheid C, Nockemann S, Pilz K, Seghrouchni S, Mackenzie C, Hadding U.

Eur J Immunol. 1996 Feb;26(2):487-92.

PMID:
8617321
30.

Toxoplasma proteins recognized by protective T lymphocytes.

Fischer HG, Reichmann G, Hadding U.

Curr Top Microbiol Immunol. 1996;219:175-82. No abstract available.

PMID:
8791699
31.
32.
33.

Properties of voltage-gated currents of microglia developed using macrophage colony-stimulating factor.

Eder C, Fischer HG, Hadding U, Heinemann U.

Pflugers Arch. 1995 Aug;430(4):526-33.

PMID:
7491279
34.

Heparin inhibits the antiparasitic and immune modulatory effects of human recombinant interferon-gamma.

Däubener W, Nockemann S, Gutsche M, Hadding U.

Eur J Immunol. 1995 Mar;25(3):688-92.

PMID:
7705397
35.

Cytokine-dependent K+ channel profile of microglia at immunologically defined functional states.

Fischer HG, Eder C, Hadding U, Heinemann U.

Neuroscience. 1995 Jan;64(1):183-91.

PMID:
7535902
36.

Possible transmission of sarcoidosis via allogeneic bone marrow transplantation.

Heyll A, Meckenstock G, Aul C, Söhngen D, Borchard F, Hadding U, Mödder U, Leschke M, Schneider W.

Bone Marrow Transplant. 1994 Jul;14(1):161-4.

PMID:
7951107
37.

A new, simple, bioassay for human IFN-gamma.

Däubener W, Wanagat N, Pilz K, Seghrouchni S, Fischer HG, Hadding U.

J Immunol Methods. 1994 Jan 12;168(1):39-47.

PMID:
8288893
38.

Cytoadhesins of Mycoplasma hominis.

Henrich B, Feldmann RC, Hadding U.

Infect Immun. 1993 Jul;61(7):2945-51.

40.

Improvement of Clostridium difficile isolation by heat-shock and typing of the isolated strains by SDS-PAGE.

Lahn M, Tyler G, Däubener W, Hadding U.

Eur J Epidemiol. 1993 May;9(3):327-34.

PMID:
8405320
41.

Induction of toxoplasmostasis in a human glioblastoma by interferon gamma.

Däubener W, Pilz K, Seghrouchni Zennati S, Bilzer T, Fischer HG, Hadding U.

J Neuroimmunol. 1993 Mar;43(1-2):31-8.

PMID:
8384636
42.

Differentiation driven by granulocyte-macrophage colony-stimulating factor endows microglia with interferon-gamma-independent antigen presentation function.

Fischer HG, Nitzgen B, Germann T, Degitz K, Däubener W, Hadding U.

J Neuroimmunol. 1993 Jan;42(1):87-95.

PMID:
8093703
43.

Human glioblastoma cell line 86HG39 activates T cells in an antigen specific major histocompatibility complex class II-dependent manner.

Däubener W, Zennati SS, Wernet P, Bilzer T, Fischer HG, Hadding U.

J Neuroimmunol. 1992 Nov;41(1):21-8.

PMID:
1460090
44.

[Current developments in the use of antibiotics in gynecology and obstetrics].

Thomas L, Hadding U.

Gynakologe. 1992 Aug;25(4):220-5. Review. German. No abstract available.

PMID:
1398250
45.

Monoclonal antibodies specific for Clostridium difficile toxin B and their use in immunoassays.

Müller F, Stiegler C, Hadding U.

J Clin Microbiol. 1992 Jun;30(6):1544-50.

46.

Species differentiation of mycoplasmas by EF-Tu specific monoclonal antibodies.

Kamla V, Henrich B, Hadding U.

J Immunol Methods. 1992 Feb 14;147(1):73-81.

PMID:
1371797
47.

[A lethal course in pseudomembranous enterocolitis during the parenteral administration of vancomycin and imipenem].

Arning M, Gehrt A, Wolf M, Aul C, Chlebowski H, Hadding U, Schneider W.

Dtsch Med Wochenschr. 1992 Jan 17;117(3):91-5. German.

PMID:
1730214
48.

Decreased metabolism and viability of Mycoplasma hominis induced by monoclonal antibody-mediated agglutination.

Feldmann RC, Henrich B, Kolb-Bachofen V, Hadding U.

Infect Immun. 1992 Jan;60(1):166-74.

49.

Granulocyte colony-stimulating factor (G-CSF) treatment in a neutropenic leukemia patient with diffuse interstitial pulmonary infiltrates.

Heyll A, Aul C, Gogolin F, Thomas M, Arning M, Gehrt A, Hadding U.

Ann Hematol. 1991 Dec;63(6):328-32.

PMID:
1721841
50.

Morphological changes in adherent cells induced by Clostridium difficile toxins.

von Eichel-Streiber C, Warfolomeow I, Knautz D, Sauerborn M, Hadding U.

Biochem Soc Trans. 1991 Nov;19(4):1154-60. No abstract available.

PMID:
1794484

Supplemental Content

Loading ...
Support Center